Aug. 31, 2026 — Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
Aug. 31, 2026 — At the European Society of Cardiology Congress in Munich, Abbott announced new late-breaking 12-month ...
Aug. 26, 2026 – The Cardiovascular Research Foundation (CRF) announced the late-breaking clinical trials and science sel ...
Aug. 21, 2026 — Milestone Pharmaceuticals Inc. has announced that the first patient has been enrolled in the Phase 3 ...
Aug. 24, 2026 — The VIVA Foundation will spotlight the latest advances in vascular medicine as 26 clinical trials are ...
Aug. 20, 2026 — A new study found that nearly 8 out of 10 young adult participants, average age 23 years, had cardiovasc ...
Aug. 13, 2026 — Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the ...
Aug. 4, 2026 — Abbott has completed enrollment in its TECTONIC coronary artery disease (CAD) Intravascular Lithotripsy ...
July 23, 2026 — The results of 59 ground-breaking trials will be unveiled for the first time at ESC Congress 2026, the ...
July 21, 2026 — Women who experience pregnancy complications face an increased risk of developing peripheral artery ...
July 20, 2026 — Young women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovarian ...
July 9, 2026 — A new artificial intelligence (AI) clinical tool developed by researchers at the University of Maryland ...
June 25, 2026 — Johnson & Johnson has announced the initiation of its Skyward investigational device exemption (IDE) ...
June 23, 2026 — The European Society of Cardiology (ESC) Congress 2026 will take place in Munich Aug. 28–31, 2026. ESC ...
June 17, 2026 — VahatiCor, Inc., a medtech company developing interventional therapies for coronary microvascular ...
September 02, 2026